| 英文别名: |
1-Hydroxyurea;biosupressin;carbamohydroxamicacid;carbamohydroxyamicacid;Carbamoylhydroxylamine;carbamoyloxime;carbamylhydroxamate;hidrix;Hydroxyurea;HYDROXYCARBAMIDE;1-hydroxyure;amino-hydroxamic acid;Droxia;Hydrea;HYDROXYCARBAMIDE (HYDROXYUREA);HYDROXYCARBAMIDE, BP STANDARD;HYDROXYHARNSTOFF;HYDROXYHARNSTOFF(HYDROXYUREA);hydroxyl urea;hydroxyure;HYDROXYUREA (HYDROXYCARBAMIDE);Litalir;N-HYDROXYUREA;Onco-carbide;Oxyurea;NHY;hydura;sq1089;Oxyure;Siklos;hydreia;Lotus Seed Extract;hu;Carbamoyl oxime;Hydroxycarbamine;Carbamohydroximic acid;Carbamohydroxamic acid;Carbamyl hydroxamate;Urea, hydroxy-;Hydurea;N-Carbamoylhydroxylamine;Hydroxicarbamidum;Hydroxylurea;Litaler;Idrossicarbamide [DCIT];Hidroxicarbamida;Hydroxycarbamidum;Carbamohydroxyamic acid;N-Hydroxymocovina;Hydroxylamine, N-carbamoyl-;n-hydroxy-urea;Hydroxyurea, United States Pharmacopeia (USP) Reference Standard;8029-68-3;DRG-0253;Bio1_000940;Q212272;LP00596;HMS2091L17;MLS001332381;GTPL6822;MLS001332382;BRN 1741548;s1896;NCGC00015520-04;NSC-32065;Droxia (TN);HYDROXYCARBAMIDE [JAN];NCI60_002773;FT-0627175;Hydroxycarbamid;HSDB 6887;HYDROXYCARBAMIDE [MART.];AB00052018_12;STR02555;Tox21_300319;NCGC00015520-10;UNII-X6Q56QN5QC;NSC757072;4-03-00-00170 (Beilstein Handbook Reference);FT-0670210;Droxia (TM);Hydrea (Bristol Meyers);NCGC00015520-08;HMS1920F09;NSC 32065;SMR000059149;HMS2234I03;NCGC00015520-20;NINDS_000556;Pharmakon1600-01500344;NCGC00261281-01;A805636;Spectrum3_000462;KBio2_003957;KBio2_006525;Oncocarbide;HMS3655K20;AB00052018_11;SK 22591;HMS3869C03;AKOS006222547;SQ 1089;N-Hydroxymocovina [Czech];Tox21_110168_1;Mylocel;SDCCGSBI-0050578.P006;AB00052018-10;NCGC00015520-11;AC-22674;DTXSID6025438;NCIMech_000139;C07044;AB00052018-09;HMS3373G18;Hydroxyurea (Cytodrox);NCGC00093974-02;Hydroxyurea (D4);CHEBI:44423;Hydrea (TM);hydroxyaminomethanamide;S-phase/G-1 interface inhibitor;E0723DBA-5AF3-49D1-B5F6-59420AB87AC9;NCGC00015520-05;Hydroxyharnstoff [German];Hydroxylamine, N-(aminocarbonyl)-;NCGC00015520-06;NCGC00015520-02;AI3-51139;Spectrum5_000836;EU-0100596;Idrossicarbamide;tetratogen: inhibits ribonucleoside diphosphate reductase;SR-01000075919-3;aminohydroxamic acid;EN300-82775;SW218071-2;AKOS005716276;SR-01000075919-1;NCGC00093974-01;HYDROXYUREA [IARC];HYDROXYUREA [VANDF];NCGC00015520-09;SBI-0050578.P004;HYDROXYUREA [HSDB];Bio1_001429;Spectrum2_000064;Hydroxycarbamide (JAN/INN);IDI1_000556;urea, N-hydroxy-;H0310;DB01005;KBioSS_001389;BSPBio_002164;NCGC00015520-01;F8880-0905;hydroxy urea;Z1203577934;HYDREA (TN);Lopac0_000596;MLS002153389;Xromi;Bio1_000451;Spectrum4_000012;DTXCID405438;HYDROXY-UREA;HYDROXYUREA [ORANGE BOOK];HYDROXYUREA [USAN];NCGC00254007-01;CHEMBL467;KBioGR_000383;SPECTRUM1500344;HYDROXYUREA [USP MONOGRAPH];NCGC00093974-03;NSC-757072;NCI C04831;Hydroxyurea, 98%, powder;MFCD00007943;Spectrum_000909;CCG-35236;WLN: ZVMQ;Hydroxycarbamidum [INN-Latin];X6Q56QN5QC... |